Current trends in antifertility vaccine research.
We review the major advances that have recently occurred in the area of antifertility vaccines by examining the immunogenic potential of gamete, embryonic and placental antigens. In human trials using beta-human chorionic gonadotropin coupled with tetanus toxoid as the immunogen, the major problems with antifertility vaccines relate to specificity and maintaining an adequate antibody titer to disrupt gestation. Possible complications include cross-reaction with other body tissues, immune complex deposition, cytotoxicity, impaired immunologic tumor surveillance and nonreversibility.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000941:Antigens / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D006063:Chorionic Gonadotropin / Q000009:adverse effects / Q000276:immunology; D003267:Contraception; D003269:Contraception, Immunologic; D004622:Embryo, Mammalian / Q000276:immunology; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005718:Gametogenesis / Q000187:drug effects; D006801:Humans; D007114:Immunization / Q000009:adverse effects; D007519:Isoantigens / Q000276:immunology; D008297:Male; D010920:Placenta / Q000276:immunology; D011247:Pregnancy; D013094:Spermatozoa / Q000276:immunology; D014327:Trophoblasts / Q000276:immunology; D014612:Vaccines / Q000009:adverse effects / Q000494:pharmacology*; D015044:Zona Pellucida / Q000276:immunology
D000276:Adjuvants, Immunologic; D000941:Antigens; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D006063:Chorionic Gonadotropin; D007519:Isoantigens; D014612:Vaccines; C031192:oncofetal antigens